Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Sell
23,550
-5,990
-20% -$547K 0.15% 82
2026
Q1
$3.03M Sell
29,540
-740
-2% -$83.6K 0.43% 55
2025
Q4
$3.79M Sell
30,280
-3,220
-10% -$410K 0.51% 39
2025
Q3
$4.49M Sell
33,500
-700
-2% -$91.9K 0.64% 31
2025
Q2
$4.65M Sell
34,200
-240
-0.7% -$31.6K 0.73% 30
2025
Q1
$4.57M Buy
34,440
+610
+2% +$77.6K 0.87% 27
2024
Q4
$3.83M Buy
+33,830
New +$3.91M 0.68% 33

Other funds holding ABT

Sava Infond's ABT Position: Q2 2026 in Review

Sava Infond reduced its Abbott (ABT) stake by 20% in Q2 2026, selling an estimated $547K and leaving 23,550 shares worth $2.14M. The position accounts for 0.15% of the portfolio, ranked #82.

Sava Infond first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.65M in Q2 2025. 694 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Sava Infond held 23,550 shares of Abbott worth $2.14M as of Q2 2026.
  • Sava Infond sold 5,990 Abbott shares in Q2 2026, an estimated $547K.
  • Abbott made up 0.15% of Sava Infond's portfolio in Q2 2026, its #82 holding.
  • Sava Infond first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Abbott position peaked at $4.65M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.